Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

Rhea-AI Summary

Singular Genomics Systems, Inc. (Nasdaq: OMIC) will present at the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2022, in Laguna Beach, California. The company's management will participate in a fireside chat scheduled for 1:00 p.m. PT / 4:00 p.m. ET. Investors can access a live and recorded webcast of the event on the company's investor site. Singular Genomics focuses on advanced next-generation sequencing and multiomics technologies, featuring its G4 Sequencing Platform and the upcoming PX system aimed at single-cell analysis.

SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California.

Singular Genomics’ management is scheduled to participate in a fireside chat Thursday, August 11, 2022, at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

When is Singular Genomics' presentation at the UBS Genomics 2.0 Summit?

Singular Genomics will present on August 11, 2022, at 1:00 p.m. PT / 4:00 p.m. ET.

How can investors access the live presentation by Singular Genomics?

Investors can listen to the live presentation via a webcast available on Singular Genomics' investor website.

What technologies does Singular Genomics focus on?

Singular Genomics specializes in next-generation sequencing and multiomics technologies.

What is the G4 Sequencing Platform?

The G4 Sequencing Platform is a benchtop genomic sequencer designed for fast and accurate sequencing results.

What is the upcoming PX system developed by Singular Genomics?

The PX system will utilize proprietary sequencing technology for in-situ analysis of RNA and proteins in single cells and tissues.